Renexxion goes to FDA with cystic fibrosis drug
Renexxion Ireland Limited has opened an investigational new drug (IND) application with the U.S Food…
Renexxion Ireland Limited has opened an investigational new drug (IND) application with the U.S Food…
By Bob Coughlin, managing director, life sciences, JLL For the last two years, the pandemic…
U.S. company Krystal Biotech is set to start a clinical trial for cystic fibrosis after…
Carbon Biosciences, a Longwood Fund founded biotech company developing parvovirus-derived gene therapies, has launched with…
Current treatments for cystic fibrosis are not suitable for all patients and have a limited…
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
As the biotech industry flourishes and therapies become more targeted and personalized, the need for…
Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second…
The Swiss biotech Sun Bioscience has launched a robotic platform designed to standardize the production…
A new partnership in the UK will develop a gene therapy for cystic fibrosis that…
Enterprise Therapeutics has raised a substantial Series B financing round to bring its treatments for…
ProQR is the result of a personal quest against cystic fibrosis started by its CEO,…